SAN ANTONIO — The addition of palbociclib (Ibrance) to current standard-of-care therapy following induction chemotherapy resulted in a significant and clinically meaningful improvement in progression-free
NEW ORLEANS — Tenecteplase in recent years outpaced alteplase as the stroke thrombolytic of choice at one large hospital system, despite shrinking cost savings, a
Policy experts punched holes in drug companies’ claims that the Medicare Drug Price Negotiation Program will stunt innovation and weighed in on other drug price-curbing
Members of the Medicare Payment Advisory Commission (MedPAC) seemed favorable Thursday to a proposed recommendation to Congress that Medicare should pay physicians based on the
Donald Trump was on the verge of backing a 16-week federal abortion ban earlier this year when aides staged an intervention. According to Time magazine’s
The following contains links to social media websites including X, TikTok, Instagram, Facebook, and LinkedIn. “Babe, wake up, your surgery isn’t done yet but we
Actor, comedian, and singer Jamie Foxx revealed that his mystery ailment last year was a brain bleed and stroke. In his new comedy special “Jamie
SAN ANTONIO — Carriers of germline BRCA mutations diagnosed with breast cancer by age 40 who underwent risk-reducing surgeries had lower rates of mortality and
SAN ANTONIO — Active monitoring for low-risk ductal carcinoma in situ (DCIS) did not lead to a higher rate of ipsilateral invasive cancer versus guideline-recommended
The non-small cell lung cancer (NSCLC) drug osimertinib (Tagrisso) was associated with an increased risk of therapy-related cardiovascular (CV) events compared with older EGFR inhibitors,